Clinical Trials

408 enrolled

Colorectal Neoplasms

NCT06252649 2026-02-27

CodeBreaK 301

450 enrolled

Phase 3 Active not recruiting

Neoplasms, Colorectal Neoplasms

NCT05198934 2026-02-06

CodeBreak300

160 enrolled 1 FDA

Colorectal Neoplasms

NCT02885753 2025-07-09

OSCAR

348 enrolled

Phase 3 Active not recruiting

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT03635021 2024-10-21

CR-SEQUENCE

419 enrolled

Colorectal Neoplasms

NCT06509126 2024-07-19

IMPROVE-2

500 enrolled

Colorectal Neoplasms

NCT02394795 2023-11-01

PARADIGM

823 enrolled 20 charts

Colorectal Neoplasms

NCT03231722 2023-01-05

TRIPLETE

435 enrolled

Colorectal Neoplasms

NCT00113763 2022-11-07

Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer

463 enrolled 17 charts

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00364013 2022-11-07

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

1,183 enrolled 18 charts

Neoplasms, Colorectal Neoplasms

NCT01001377 2022-09-21

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

1,010 enrolled 22 charts

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00389870 2022-06-01

Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil

1,198 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03300609 2020-06-11

5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

Phase 3 Terminated

4 enrolled

Colorectal Neoplasms

NCT00115765 2018-10-17

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

1,053 enrolled 25 charts

Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01412957 2017-03-15

Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer

377 enrolled 20 charts